Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome by Bittner, Vera A., Szarek, Michael, Aylward, Philip E., Bhatt, Deepak L., Diaz, Rafael, Edelberg, Jay M., Fras, Zlatko, Goodman, Shaun G., Halvorsen, Sigrun, Hanotin, Corinne, Harrington, Robert A., Jukema, J. Wouter, Loizeau, Virginie, Moriarty, Patrick M., Moryusef, Angèle, Pordy, Robert, Roe, Matthew T., Sinnaeve, Peter, Tsimikas, Sotirios, Vogel, Robert, White, Harvey D., Zahger, Doron, Zeiher, Andreas M., Steg, Ph. Gabriel, Schwartz, Gregory G.

Get full text

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES by Jukema, J Wouter, Zijlstra, Laurien E, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Drexel, Heinz, Goodman, Shaun G, Kim, Yong-Un, Pordy, Robert, Reiner, Željko, Roe, Matthew T, Tse, Hung-Fat, Montenegro Valdovinos, Pablo Carlos, White, Harvey D, Zeiher, Andreas M, Szarek, Michael, Schwartz, Gregory G, Steg, Philippe Gabriel

Get full text

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol by Schwartz, Gregory G, Szarek, Michael, Bittner, Vera A, Diaz, Rafael, Goodman, Shaun G, Jukema, J Wouter, Landmesser, Ulf, López-Jaramillo, Patricio, Manvelian, Garen, Pordy, Robert, Scemama, Michel, Sinnaeve, Peter R, White, Harvey D, Gabriel Steg, Ph

Get full text

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery by Goodman, Shaun G., Aylward, Philip E., Szarek, Michael, Chumburidze, Vakhtang, Bhatt, Deepak L., Bittner, Vera A., Diaz, Rafael, Edelberg, Jay M., Hanotin, Corinne, Harrington, Robert A., Jukema, J. Wouter, Kedev, Sasko, Letierce, Alexia, Moryusef, Angele, Pordy, Robert, Ramos López, Gabriel Arturo, Roe, Matthew T., Viigimaa, Margus, White, Harvey D., Zeiher, Andreas M., Steg, Ph. Gabriel, Schwartz, Gregory G.

Get full text

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation by Goodman, Shaun G, Steg, Philippe Gabriel, Szarek, Michael, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Harrington, Robert A, Jukema, J Wouter, White, Harvey D, Zeiher, Andreas M, Manvelian, Garen, Pordy, Robert, Poulouin, Yann, Stipek, Wanda, Garon, Genevieve, Schwartz, Gregory G

Get full text

Abstract 11149: Effect of Low-density Lipoprotein Cholesterol Lowering With Alirocumab on Stroke in ODYSSEY OUTCOMES by Jukema, J Wouter, Szarek, Michael, Zijlstra, Laurien, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Drexel, Heinz, Goodman, Shaun G, Harrington, Robert A, Kim, Yong-Un, Louie, Michael J, Pordy, Robert, Reiner, Zeljko, Roe, Matthew T, Tse, Hung-Fat, Montenegro Valdovinos, Pablo Carlos, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G, Steg, Philippe G

Get full text

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab by Hagström, Emil, Steg, P. Gabriel, Szarek, Michael, Bhatt, Deepak L., Bittner, Vera A., Danchin, Nicolas, Diaz, Rafael, Goodman, Shaun G., Harrington, Robert A., Jukema, J. Wouter, Liberopoulos, Evangelos, Marx, Nikolaus, McGinniss, Jennifer, Manvelian, Garen, Pordy, Robert, Scemama, Michel, White, Harvey D., Zeiher, Andreas M., Schwartz, Gregory G.

Get full text